Creative Medical Technology Holdings, Inc. Interest Income (Expense), after Provision for Loan Loss
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest Income (Expense), after Provision for Loan Loss of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseAfterProvisionForLoanLoss · last filed 2022-05-13
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for the quarter ending 2022-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for the quarter ending 2021-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for the quarter ending 2021-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for the quarter ending 2021-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for fiscal 2021 was $0.00.
- Creative Medical Technology Holdings, Inc. interest income (expense), after provision for loan loss for fiscal 2020 was $0.00.
| Period end | Interest Income (Expense), after Provision for Loan Loss 3 month | Interest Income (Expense), after Provision for Loan Loss 6 month | Interest Income (Expense), after Provision for Loan Loss 9 month | Interest Income (Expense), after Provision for Loan Loss 12 month |
|---|---|---|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | $0.00 derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | $0.00 derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | $0.00 derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |